1 |
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J 2018;39:3021-104.
DOI
|
2 |
Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. Korea health statistics 2016: Korea National Health and Nutrition Examination Survey (KNHANES VII-1). Cheongju: Korea Centers for Disease Control and Prevention; 2017.
|
3 |
Park JH. Antihypertensive drug medication adherence of National Health Insurance beneficiaries and its affecting factors in Korea [dissertation]. Seoul: Seoul National University; 2006.
|
4 |
World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
|
5 |
Jones CL, Jensen JD, Scherr CL, Brown NR, Christy K, Weaver J. The health belief model as an explanatory framework in communication research: exploring parallel, serial, and moderated mediation. Health Commun 2015;30:566-76.
DOI
|
6 |
Yue Z, Li C, Weilin Q, Bin W. Application of the health belief model to improve the understanding of antihypertensive medication adherence among Chinese patients. Patient Educ Couns 2015;98:669-73.
DOI
|
7 |
Choi HY, Oh IJ, Lee JA, Lim J, Kim YS, Jeon TH, et al. Factors affecting adherence to antihypertensive medication. Korean J Fam Med 2018;39:325-32.
DOI
|
8 |
Jung Y, Byeon J. The association between having a usual source of care and adherence to medicines in patients with chronic diseases. Korean J Clin Pharm 2016;26:128-36.
|
9 |
Elliott WJ. Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy. J Clin Hypertens (Greenwich) 2009;11:376-82.
DOI
|
10 |
Burnier M. Drug adherence in hypertension. Pharmacol Res 2017;125(Pt B):142-9.
DOI
|
11 |
Kim JA, Kim ES, Lee EK. Evaluation of the chronic disease management program for appropriateness of medication adherence and persistence in hypertension and type-2 diabetes patients in Korea. Medicine (Baltimore) 2017;96:e6577.
DOI
|